ArticleCancer medicine2019

Internal enhancement of DNA damage by a novel bispecific antibody-drug conjugate-like therapeutics via blockage of mTOR and PD-L1 signal pathways in pancreatic cancer.

Rui Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.